Aquestive Therapeutics Inc — 貸借対照表 (NASDAQ:AQST) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 62.88 M61.99 M57.07 M57.42 M101.42 M160.43 M 負債合計 111.38 M144.13 M175.62 M163.91 M161.58 M194.09 M 純資産合計 -48.5 M-82.13 M-118.55 M-106.49 M-60.16 M-33.66 M 負債および純資産合計 62.88 M61.99 M57.07 M57.42 M101.42 M160.43 M 有利子負債合計 36.9 M53.58 M52.15 M50.81 M50.48 M49.97 M 純負債 5.1 M53.58 M52.15 M50.81 M50.48 M49.97 M

ニュース

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)

Aquestive Therapeuticsの最高人事責任者Boyd氏が12万4000ドル相当の株式を売却

Aquestive Therapeutics chief people officer Boyd sells $124k in stock

Aquestive TherapeuticsのCEO Barberが75万3965ドル相当の株式を売却

Aquestive TherapeuticsのSVP Cioffiが10万5000ドル相当の株式を売却

Aquestive Therapeuticsの最高法務責任者Braenderが16万7000ドル相当の株式を売却

Aquestive Therapeutics CEO Barber sells $753,965 in stock

Aquestive Therapeutics SVP Cioffi sells $105k in shares

Aquestive therapeutics chief legal officer Braender sells $167k in stock

Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval

Aquestive、Leerinkカンファレンスでアナフィルムに戦略的注力